Valsts valodas centra izstrādātie medicīnas zinātņu, farmācijas un veterinārmedicīnas termini

Konteksts: [..] Safety issues arising from immune response to the medicinal products or to the expressed proteins, immune rejection, immuno-suppression, and breakdown of immuno-isolation devices shall be considered [..]
Avots: Commission directive 2003/63/EC of 25 June 2003 amending Directive 2001/83/EC of the European Parliament and of the Council on the Community code relating to medicinal products for human use (Text with EEA relevance)